What Is GLP-4? A Search of the Literature for a Peptide That Does Not Appear in It
A term has been circulating in grey-market listings: GLP-4, presented as the successor to the incretin peptides that came before it. Before assessing any such claim, a laboratory needs a prior question answered — does the molecule exist in the published record at all? We searched PubMed and the clinical trial registries on 2 August…
